エストロゲン・プロゲステロンの世界市場レポート2020

• 英文タイトル：Global Estrogen and Progesterone Sales Market Report 2020

• レポートコード：20QY06-00972 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Multi User	￥888,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,184,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、エストロゲン・プロゲステロンのグローバル市場について種類別（アグレプリストン、ミフェプリストン、アソプリニル、テラプリストン、ウリプリスタルアセテート）、用途別（薬局、病院、内分泌科）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・エストロゲン・プロゲステロン市場の概要 ・世界の主要地域別エストロゲン・プロゲステロン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のエストロゲン・プロゲステロン市場規模2015-2026：種類別（アグレプリストン、ミフェプリストン、アソプリニル、テラプリストン、ウリプリスタルアセテート） ・世界のエストロゲン・プロゲステロン市場規模2015-2026：用途別（薬局、病院、内分泌科） ・エストロゲン・プロゲステロンの北米市場規模2015-2020 ・エストロゲン・プロゲステロンのヨーロッパ市場規模2015-2020 ・エストロゲン・プロゲステロンの中国市場規模2015-2020 ・エストロゲン・プロゲステロンの日本市場規模2015-2020 ・エストロゲン・プロゲステロンの東南アジア市場規模2015-2020 ・エストロゲン・プロゲステロンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Gedeon Richter Plc.、Bayer Oy、N.V.Organon、Pfizer Healthcare Ireland、Jenapharm GmbH & Co. KG、Besins Healthcare Benelux、MERCK SERONO LIMITED、Abbott Healthcare Products B.V.、Teva Pharma - Produtos Farmaceuticos,Lda.、Aspen Pharmacare Australia Pty Ltd.、Dr.Kade Pharmazeutische Fabrik GmbH、F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.、Eli Lilly Nederland B.V、Orion Corporation、AstraZeneca UK Limited、Novartis Pharma Schweiz AG） ・エストロゲン・プロゲステロンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・エストロゲン・プロゲステロンの市場動向・機会・課題 ・調査の結論

Market Analysis and Insights: Global Estrogen and Progesterone Market
The global Estrogen and Progesterone market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Estrogen and Progesterone Scope and Market Size
The global Estrogen and Progesterone market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Estrogen and Progesterone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Estrogen and Progesterone market is segmented into
Aglepristone
Mifepristone
Asoprisnil
Telapristone
Ulipristal Acetate

Segment by Application, the Estrogen and Progesterone market is segmented into
Pharmacy
Hospital
Department of Endocrinology
The Estrogen and Progesterone market is analysed and market size information is provided by regions (countries). Segment by Application, the Estrogen and Progesterone market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Estrogen and Progesterone Market Share Analysis
Estrogen and Progesterone market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Estrogen and Progesterone business, the date to enter into the Estrogen and Progesterone market, Estrogen and Progesterone product introduction, recent developments, etc.
The major vendors covered:
Gedeon Richter Plc.
Bayer Oy
N.V.Organon
Pfizer Healthcare Ireland
Jenapharm GmbH & Co. KG
Besins Healthcare Benelux
MERCK SERONO LIMITED
Abbott Healthcare Products B.V.
Teva Pharma – Produtos Farmaceuticos,Lda.
Aspen Pharmacare Australia Pty Ltd.
Dr.Kade Pharmazeutische Fabrik GmbH
F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.
Eli Lilly Nederland B.V
Orion Corporation
AstraZeneca UK Limited
Novartis Pharma Schweiz AG

レポート目次

---

Table of Contents

1 Estrogen and Progesterone Market Overview
1.1 Estrogen and Progesterone Product Scope
1.2 Estrogen and Progesterone Segment by Type
1.2.1 Global Estrogen and Progesterone Sales by Type (2020-2026)
1.2.2 Aglepristone
1.2.3 Mifepristone
1.2.4 Asoprisnil
1.2.5 Telapristone
1.2.6 Ulipristal Acetate
1.3 Estrogen and Progesterone Segment by Application
1.3.1 Global Estrogen and Progesterone Sales Comparison by Application (2020-2026)
1.3.2 Pharmacy
1.3.3 Hospital
1.3.4 Department of Endocrinology
1.4 Estrogen and Progesterone Market Estimates and Forecasts (2015-2026)
1.4.1 Global Estrogen and Progesterone Sales Growth Rate (2015-2026)
1.4.2 Global Estrogen and Progesterone Revenue and Growth Rate (2015-2026)
1.4.3 Global Estrogen and Progesterone Price Trends (2015-2026)

2 Estrogen and Progesterone Estimate and Forecast by Region
2.1 Global Estrogen and Progesterone Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Estrogen and Progesterone Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Estrogen and Progesterone Sales Market Share by Region (2015-2020)
2.2.2 Global Estrogen and Progesterone Revenue Market Share by Region (2015-2020)
2.3 Global Estrogen and Progesterone Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Estrogen and Progesterone Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Estrogen and Progesterone Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Estrogen and Progesterone Estimates and Projections (2015-2026)
2.4.2 Europe Estrogen and Progesterone Estimates and Projections (2015-2026)
2.4.3 China Estrogen and Progesterone Estimates and Projections (2015-2026)
2.4.4 Japan Estrogen and Progesterone Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Estrogen and Progesterone Estimates and Projections (2015-2026)
2.4.6 India Estrogen and Progesterone Estimates and Projections (2015-2026)
3 Global Estrogen and Progesterone Competition Landscape by Players
3.1 Global Top Estrogen and Progesterone Players by Sales (2015-2020)
3.2 Global Top Estrogen and Progesterone Players by Revenue (2015-2020)
3.3 Global Estrogen and Progesterone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Estrogen and Progesterone as of 2019)
3.4 Global Estrogen and Progesterone Average Price by Company (2015-2020)
3.5 Manufacturers Estrogen and Progesterone Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Estrogen and Progesterone Players (Opinion Leaders)
4 Global Estrogen and Progesterone Market Size by Type
4.1 Global Estrogen and Progesterone Historic Market Review by Type (2015-2020)
4.1.1 Global Estrogen and Progesterone Sales Market Share by Type (2015-2020)
4.1.2 Global Estrogen and Progesterone Revenue Market Share by Type (2015-2020)
4.1.3 Global Estrogen and Progesterone Price by Type (2014-2020)
4.2 Global Estrogen and Progesterone Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Estrogen and Progesterone Sales Forecast by Type (2021-2026)
4.2.2 Global Estrogen and Progesterone Revenue Forecast by Type (2021-2026)
4.2.3 Global Estrogen and Progesterone Price Forecast by Type (2021-2026)
5 Global Estrogen and Progesterone Market Size by Application
5.1 Global Estrogen and Progesterone Historic Market Review by Application (2015-2020)
5.1.1 Global Estrogen and Progesterone Sales Market Share by Application (2015-2020)
5.1.2 Global Estrogen and Progesterone Revenue Market Share by Application (2015-2020)
5.1.3 Global Estrogen and Progesterone Price by Application (2015-2020)
5.2 Global Estrogen and Progesterone Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Estrogen and Progesterone Sales Forecast by Application (2021-2026)
5.2.2 Global Estrogen and Progesterone Revenue Forecast by Application (2021-2026)
5.2.3 Global Estrogen and Progesterone Price Forecast by Application (2021-2026)

3 North America Estrogen and Progesterone Market Facts & Figures
3.2 North America Estrogen and Progesterone Sales Market Share by Company (2015-2020)
3.3 North America Estrogen and Progesterone Sales Market Share by Type (2015-2020)
3.4 North America Estrogen and Progesterone Sales Market Share by Application (2015-2020)

4 Europe Estrogen and Progesterone Market Facts & Figures
4.2 Europe Estrogen and Progesterone Sales Market Share by Company (2015-2020)
4.3 Europe Estrogen and Progesterone Sales Market Share by Type (2015-2020)
4.4 Europe Estrogen and Progesterone Sales Market Share by Application (2015-2020)

5 China Estrogen and Progesterone Market Facts & Figures
5.2 China Estrogen and Progesterone Sales Market Share by Company (2015-2020)
5.3 China Estrogen and Progesterone Sales Market Share by Type (2015-2020)
5.4 China Estrogen and Progesterone Sales Market Share by Application (2015-2020)

6 Japan Estrogen and Progesterone Market Facts & Figures
6.2 Japan Estrogen and Progesterone Sales Market Share by Company (2015-2020)
6.3 Japan Estrogen and Progesterone Sales Market Share by Type (2015-2020)
6.4 Japan Estrogen and Progesterone Sales Market Share by Application (2015-2020)

7 Southeast Asia Estrogen and Progesterone Market Facts & Figures
7.2 Southeast Asia Estrogen and Progesterone Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Estrogen and Progesterone Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Estrogen and Progesterone Sales Market Share by Application (2015-2020)

8 India Estrogen and Progesterone Market Facts & Figures
8.2 India Estrogen and Progesterone Sales Market Share by Company (2015-2020)
8.3 India Estrogen and Progesterone Sales Market Share by Type (2015-2020)
8.4 India Estrogen and Progesterone Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Estrogen and Progesterone Business
12.1 Gedeon Richter Plc.
12.1.1 Gedeon Richter Plc. Estrogen and Progesterone Corporation Information
12.1.2 Gedeon Richter Plc. Estrogen and Progesterone Business Overview and Total Revenue
12.1.3 Gedeon Richter Plc. Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Gedeon Richter Plc. Estrogen and Progesterone Products Offered
12.1.5 Gedeon Richter Plc. Recent Development
12.2 Bayer Oy
12.2.1 Bayer Oy Estrogen and Progesterone Corporation Information
12.2.2 Bayer Oy Estrogen and Progesterone Business Overview and Total Revenue
12.2.3 Bayer Oy Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer Oy Estrogen and Progesterone Products Offered
12.2.5 Bayer Oy Recent Development
12.3 N.V.Organon
12.3.1 N.V.Organon Estrogen and Progesterone Corporation Information
12.3.2 N.V.Organon Estrogen and Progesterone Business Overview and Total Revenue
12.3.3 N.V.Organon Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.3.4 N.V.Organon Estrogen and Progesterone Products Offered
12.3.5 N.V.Organon Recent Development
12.4 Pfizer Healthcare Ireland
12.4.1 Pfizer Healthcare Ireland Estrogen and Progesterone Corporation Information
12.4.2 Pfizer Healthcare Ireland Estrogen and Progesterone Business Overview and Total Revenue
12.4.3 Pfizer Healthcare Ireland Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Healthcare Ireland Estrogen and Progesterone Products Offered
12.4.5 Pfizer Healthcare Ireland Recent Development
12.5 Jenapharm GmbH & Co. KG
12.5.1 Jenapharm GmbH & Co. KG Estrogen and Progesterone Corporation Information
12.5.2 Jenapharm GmbH & Co. KG Estrogen and Progesterone Business Overview and Total Revenue
12.5.3 Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Jenapharm GmbH & Co. KG Estrogen and Progesterone Products Offered
12.5.5 Jenapharm GmbH & Co. KG Recent Development
12.6 Besins Healthcare Benelux
12.6.1 Besins Healthcare Benelux Estrogen and Progesterone Corporation Information
12.6.2 Besins Healthcare Benelux Estrogen and Progesterone Business Overview and Total Revenue
12.6.3 Besins Healthcare Benelux Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Besins Healthcare Benelux Estrogen and Progesterone Products Offered
12.6.5 Besins Healthcare Benelux Recent Development
12.7 MERCK SERONO LIMITED
12.7.1 MERCK SERONO LIMITED Estrogen and Progesterone Corporation Information
12.7.2 MERCK SERONO LIMITED Estrogen and Progesterone Business Overview and Total Revenue
12.7.3 MERCK SERONO LIMITED Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.7.4 MERCK SERONO LIMITED Estrogen and Progesterone Products Offered
12.7.5 MERCK SERONO LIMITED Recent Development
12.8 Abbott Healthcare Products B.V.
12.8.1 Abbott Healthcare Products B.V. Estrogen and Progesterone Corporation Information
12.8.2 Abbott Healthcare Products B.V. Estrogen and Progesterone Business Overview and Total Revenue
12.8.3 Abbott Healthcare Products B.V. Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Abbott Healthcare Products B.V. Estrogen and Progesterone Products Offered
12.8.5 Abbott Healthcare Products B.V. Recent Development
12.9 Teva Pharma – Produtos Farmaceuticos,Lda.
12.9.1 Teva Pharma – Produtos Farmaceuticos,Lda. Estrogen and Progesterone Corporation Information
12.9.2 Teva Pharma – Produtos Farmaceuticos,Lda. Estrogen and Progesterone Business Overview and Total Revenue
12.9.3 Teva Pharma – Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Teva Pharma – Produtos Farmaceuticos,Lda. Estrogen and Progesterone Products Offered
12.9.5 Teva Pharma – Produtos Farmaceuticos,Lda. Recent Development
12.10 Aspen Pharmacare Australia Pty Ltd.
12.10.1 Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Corporation Information
12.10.2 Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Business Overview and Total Revenue
12.10.3 Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Products Offered
12.10.5 Aspen Pharmacare Australia Pty Ltd. Recent Development
12.11 Dr.Kade Pharmazeutische Fabrik GmbH
12.11.1 Dr.Kade Pharmazeutische Fabrik GmbH Estrogen and Progesterone Corporation Information
12.11.2 Dr.Kade Pharmazeutische Fabrik GmbH Estrogen and Progesterone Business Overview and Total Revenue
12.11.3 Dr.Kade Pharmazeutische Fabrik GmbH Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Dr.Kade Pharmazeutische Fabrik GmbH Estrogen and Progesterone Products Offered
12.11.5 Dr.Kade Pharmazeutische Fabrik GmbH Recent Development
12.12 F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.
12.12.1 F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Estrogen and Progesterone Corporation Information
12.12.2 F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Estrogen and Progesterone Business Overview and Total Revenue
12.12.3 F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.12.4 F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Estrogen and Progesterone Products Offered
12.12.5 F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Recent Development
12.13 Eli Lilly Nederland B.V
12.13.1 Eli Lilly Nederland B.V Estrogen and Progesterone Corporation Information
12.13.2 Eli Lilly Nederland B.V Estrogen and Progesterone Business Overview and Total Revenue
12.13.3 Eli Lilly Nederland B.V Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Eli Lilly Nederland B.V Estrogen and Progesterone Products Offered
12.13.5 Eli Lilly Nederland B.V Recent Development
12.14 Orion Corporation
12.14.1 Orion Corporation Estrogen and Progesterone Corporation Information
12.14.2 Orion Corporation Estrogen and Progesterone Business Overview and Total Revenue
12.14.3 Orion Corporation Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Orion Corporation Estrogen and Progesterone Products Offered
12.14.5 Orion Corporation Recent Development
12.15 AstraZeneca UK Limited
12.15.1 AstraZeneca UK Limited Estrogen and Progesterone Corporation Information
12.15.2 AstraZeneca UK Limited Estrogen and Progesterone Business Overview and Total Revenue
12.15.3 AstraZeneca UK Limited Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.15.4 AstraZeneca UK Limited Estrogen and Progesterone Products Offered
12.15.5 AstraZeneca UK Limited Recent Development
12.16 Novartis Pharma Schweiz AG
12.16.1 Novartis Pharma Schweiz AG Estrogen and Progesterone Corporation Information
12.16.2 Novartis Pharma Schweiz AG Estrogen and Progesterone Business Overview and Total Revenue
12.16.3 Novartis Pharma Schweiz AG Estrogen and Progesterone Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Novartis Pharma Schweiz AG Estrogen and Progesterone Products Offered
12.16.5 Novartis Pharma Schweiz AG Recent Development

13 Estrogen and Progesterone Manufacturing Cost Analysis
13.1 Estrogen and Progesterone Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Estrogen and Progesterone
13.4 Estrogen and Progesterone Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Estrogen and Progesterone Distributors List
14.3 Estrogen and Progesterone Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Estrogen and Progesterone Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Estrogen and Progesterone Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Estrogen and Progesterone Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Estrogen and Progesterone Sales (K Pcs) by Region (2015-2020)
Table 5. Global Estrogen and Progesterone Sales Market Share by Region (2015-2020)
Table 6. Global Estrogen and Progesterone Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Estrogen and Progesterone Revenue Share by Region (2015-2020)
Table 8. Global Estrogen and Progesterone Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Estrogen and Progesterone Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Estrogen and Progesterone Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Estrogen and Progesterone Revenue Share Forecast by Region (2021-2026)
Table 12. Global Estrogen and Progesterone (K Pcs) of Key Companies (2015-2020)
Table 13. Global Estrogen and Progesterone Sales Share by Company (2015-2020)
Table 14. Global Estrogen and Progesterone Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Estrogen and Progesterone Revenue Share by Company (2015-2020)
Table 16. Global Estrogen and Progesterone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Estrogen and Progesterone as of 2019)
Table 17. Global Estrogen and Progesterone Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Estrogen and Progesterone Manufacturing Sites and Area Served
Table 19. Manufacturers Estrogen and Progesterone Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Estrogen and Progesterone Players
Table 22. Global Estrogen and Progesterone Sales (K Pcs) by Type (2015-2020)
Table 23. Global Estrogen and Progesterone Sales Share by Type (2015-2020)
Table 24. Global Estrogen and Progesterone Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Estrogen and Progesterone Price (K Pcs) by Type (2015-2020)
Table 26. Global Estrogen and Progesterone Sales Share by Type (2021-2026)
Table 27. Global Estrogen and Progesterone Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Estrogen and Progesterone Revenue Share by Type (2021-2026)
Table 29. Global Estrogen and Progesterone Price (K Pcs) by Type (2021-2026)
Table 30. Global Estrogen and Progesterone Sales (K Pcs) by Application (2015-2020)
Table 31. Global Estrogen and Progesterone Sales Share by Application (2015-2020)
Table 32. Global Estrogen and Progesterone Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Estrogen and Progesterone Price (K Pcs) by Application (2015-2020)
Table 34. Global Estrogen and Progesterone Sales (K Pcs) by Application (2021-2026)
Table 35. Global Estrogen and Progesterone Sales Share by Application (2021-2026)
Table 36. Global Estrogen and Progesterone Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Estrogen and Progesterone Revenue Share by Application (2021-2026)
Table 38. Global Estrogen and Progesterone Price (K Pcs) by Application (2021-2026)
Table 39. United States Estrogen and Progesterone Sales (K Pcs) by Company (2015-2020)
Table 40. United States Estrogen and Progesterone Sales Market Share by Company (2015-2020)
Table 41. United States Estrogen and Progesterone Sales (K Pcs) by Type (2015-2020)
Table 42. United States Estrogen and Progesterone Sales Market Share by Type (2015-2020)
Table 43. United States Estrogen and Progesterone Sales (K Pcs) by Application (2015-2020)
Table 44. United States Estrogen and Progesterone Sales Market Share by Application (2015-2020)
Table 45. Europe Estrogen and Progesterone Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Estrogen and Progesterone Sales Market Share by Company (2015-2020)
Table 47. Europe Estrogen and Progesterone Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Estrogen and Progesterone Sales Market Share by Type (2015-2020)
Table 49. Europe Estrogen and Progesterone Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Estrogen and Progesterone Sales Market Share by Type (2015-2020)
Table 51. China Estrogen and Progesterone Sales (K Pcs) by Company (2015-2020)
Table 52. China Estrogen and Progesterone Sales Market Share by Company (2015-2020)
Table 53. China Estrogen and Progesterone Sales (K Pcs) by Type (2015-2020)
Table 54. China Estrogen and Progesterone Sales Market Share by Type (2015-2020)
Table 55. China Estrogen and Progesterone Sales (K Pcs) by Application (2015-2020)
Table 56. China Estrogen and Progesterone Sales Market Share by Application (2015-2020)
Table 57. Japan Estrogen and Progesterone Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Estrogen and Progesterone Sales Market Share by Company (2015-2020)
Table 59. Japan Estrogen and Progesterone Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Estrogen and Progesterone Sales Market Share by Type (2015-2020)
Table 61. Japan Estrogen and Progesterone Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Estrogen and Progesterone Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Estrogen and Progesterone Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Estrogen and Progesterone Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Estrogen and Progesterone Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Estrogen and Progesterone Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Estrogen and Progesterone Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Estrogen and Progesterone Sales Market Share by Application (2015-2020)
Table 69. India Estrogen and Progesterone Sales (K Pcs) by Company (2015-2020)
Table 70. India Estrogen and Progesterone Sales Market Share by Company (2015-2020)
Table 71. India Estrogen and Progesterone Sales (K Pcs) by Type (2015-2020)
Table 72. India Estrogen and Progesterone Sales Market Share by Type (2015-2020)
Table 73. India Estrogen and Progesterone Sales (K Pcs) by Application (2015-2020)
Table 74. India Estrogen and Progesterone Sales Market Share by Application (2015-2020)
Table 75. Gedeon Richter Plc. Corporation Information
Table 76. Gedeon Richter Plc. Description and Business Overview
Table 77. Gedeon Richter Plc. Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Gedeon Richter Plc. Estrogen and Progesterone Product
Table 79. Gedeon Richter Plc. Recent Development
Table 80. Bayer Oy Corporation Information
Table 81. Bayer Oy Description and Business Overview
Table 82. Bayer Oy Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Bayer Oy Estrogen and Progesterone Product
Table 84. Bayer Oy Recent Development
Table 85. N.V.Organon Corporation Information
Table 86. N.V.Organon Description and Business Overview
Table 87. N.V.Organon Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. N.V.Organon Estrogen and Progesterone Product
Table 89. N.V.Organon Recent Development
Table 90. Pfizer Healthcare Ireland Corporation Information
Table 91. Pfizer Healthcare Ireland Description and Business Overview
Table 92. Pfizer Healthcare Ireland Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Pfizer Healthcare Ireland Estrogen and Progesterone Product
Table 94. Pfizer Healthcare Ireland Recent Development
Table 95. Jenapharm GmbH & Co. KG Corporation Information
Table 96. Jenapharm GmbH & Co. KG Description and Business Overview
Table 97. Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Jenapharm GmbH & Co. KG Estrogen and Progesterone Product
Table 99. Jenapharm GmbH & Co. KG Recent Development
Table 100. Besins Healthcare Benelux Corporation Information
Table 101. Besins Healthcare Benelux Description and Business Overview
Table 102. Besins Healthcare Benelux Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Besins Healthcare Benelux Estrogen and Progesterone Product
Table 104. Besins Healthcare Benelux Recent Development
Table 105. MERCK SERONO LIMITED Corporation Information
Table 106. MERCK SERONO LIMITED Description and Business Overview
Table 107. MERCK SERONO LIMITED Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. MERCK SERONO LIMITED Estrogen and Progesterone Product
Table 109. MERCK SERONO LIMITED Recent Development
Table 110. Abbott Healthcare Products B.V. Corporation Information
Table 111. Abbott Healthcare Products B.V. Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Abbott Healthcare Products B.V. Description and Business Overview
Table 113. Abbott Healthcare Products B.V. Estrogen and Progesterone Product
Table 114. Abbott Healthcare Products B.V. Recent Development
Table 115. Teva Pharma - Produtos Farmaceuticos,Lda. Corporation Information
Table 116. Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Teva Pharma - Produtos Farmaceuticos,Lda. Description and Business Overview
Table 118. Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Product
Table 119. Teva Pharma - Produtos Farmaceuticos,Lda. Recent Development
Table 120. Aspen Pharmacare Australia Pty Ltd. Corporation Information
Table 121. Aspen Pharmacare Australia Pty Ltd. Description and Business Overview
Table 122. Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Product
Table 124. Aspen Pharmacare Australia Pty Ltd. Recent Development
Table 125. Dr.Kade Pharmazeutische Fabrik GmbH Corporation Information
Table 126. Dr.Kade Pharmazeutische Fabrik GmbH Description and Business Overview
Table 127. Dr.Kade Pharmazeutische Fabrik GmbH Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Dr.Kade Pharmazeutische Fabrik GmbH Estrogen and Progesterone Product
Table 129. Dr.Kade Pharmazeutische Fabrik GmbH Recent Development
Table 130. F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Corporation Information
Table 131. F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Description and Business Overview
Table 132. F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Estrogen and Progesterone Product
Table 134. F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Recent Development
Table 135. Eli Lilly Nederland B.V Corporation Information
Table 136. Eli Lilly Nederland B.V Description and Business Overview
Table 137. Eli Lilly Nederland B.V Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Eli Lilly Nederland B.V Estrogen and Progesterone Product
Table 139. Eli Lilly Nederland B.V Recent Development
Table 140. Orion Corporation Corporation Information
Table 141. Orion Corporation Description and Business Overview
Table 142. Orion Corporation Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. Orion Corporation Estrogen and Progesterone Product
Table 144. Orion Corporation Recent Development
Table 145. AstraZeneca UK Limited Corporation Information
Table 146. AstraZeneca UK Limited Description and Business Overview
Table 147. AstraZeneca UK Limited Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. AstraZeneca UK Limited Estrogen and Progesterone Product
Table 149. AstraZeneca UK Limited Recent Development
Table 150. Novartis Pharma Schweiz AG Corporation Information
Table 151. Novartis Pharma Schweiz AG Description and Business Overview
Table 152. Novartis Pharma Schweiz AG Estrogen and Progesterone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 153. Novartis Pharma Schweiz AG Estrogen and Progesterone Product
Table 154. Novartis Pharma Schweiz AG Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Estrogen and Progesterone Distributors List
Table 158. Estrogen and Progesterone Customers List
Table 159. Market Key Trends
Table 160. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 161. Key Challenges
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Estrogen and Progesterone Product Picture
Figure 2. Global Estrogen and Progesterone Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Estrogen and Progesterone Market Share by Application in 2020 & 2026
Figure 6. Pharmacy Examples
Figure 7. Hospital Examples
Figure 8. Department of Endocrinology Examples
Figure 9. Global Estrogen and Progesterone Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Estrogen and Progesterone Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Estrogen and Progesterone Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Estrogen and Progesterone Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Estrogen and Progesterone Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Estrogen and Progesterone Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Estrogen and Progesterone Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Estrogen and Progesterone Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Estrogen and Progesterone Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Estrogen and Progesterone Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Estrogen and Progesterone Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Estrogen and Progesterone Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Estrogen and Progesterone Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Estrogen and Progesterone Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Estrogen and Progesterone Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Estrogen and Progesterone Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Estrogen and Progesterone Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Estrogen and Progesterone Players Market Share by Revenue in Estrogen and Progesterone 2015 & 2019
Figure 27. Estrogen and Progesterone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Estrogen and Progesterone Revenue Share by Type (2015-2020)
Figure 29. Global Estrogen and Progesterone Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Estrogen and Progesterone Revenue Share by Application (2015-2020)
Figure 31. Global Estrogen and Progesterone Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Estrogen and Progesterone Sales Market Share by Type in 2019
Figure 33. United States Estrogen and Progesterone Sales Market Share by Type in 2019
Figure 34. Europe Estrogen and Progesterone Sales Market Share by Company in 2019
Figure 35. Europe Estrogen and Progesterone Sales Market Share by Type in 2019
Figure 36. Europe Estrogen and Progesterone Sales Market Share by Application in 2019
Figure 37. China Estrogen and Progesterone Sales Market Share by Company in 2019
Figure 38. China Estrogen and Progesterone Sales Market Share by Type in 2019
Figure 39. China Estrogen and Progesterone Sales Market Share by Application in 2019
Figure 40. Japan Estrogen and Progesterone Sales Market Share by Company in 2019
Figure 41. Japan Estrogen and Progesterone Sales Market Share by Type in 2019
Figure 42. Japan Estrogen and Progesterone Sales Market Share by Application in 2019
Figure 43. Southeast Asia Estrogen and Progesterone Sales Market Share by Company in 2019
Figure 44. Southeast Asia Estrogen and Progesterone Sales Market Share by Type in 2019
Figure 45. Southeast Asia Estrogen and Progesterone Sales Market Share by Application in 2019
Figure 46. India Estrogen and Progesterone Sales Market Share by Company in 2019
Figure 47. India Estrogen and Progesterone Sales Market Share by Type in 2019
Figure 48. India Estrogen and Progesterone Sales Market Share by Application in 2019
Figure 49. Gedeon Richter Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bayer Oy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. N.V.Organon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Pfizer Healthcare Ireland Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Jenapharm GmbH & Co. KG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Besins Healthcare Benelux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. MERCK SERONO LIMITED Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Abbott Healthcare Products B.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Teva Pharma - Produtos Farmaceuticos,Lda. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Aspen Pharmacare Australia Pty Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Dr.Kade Pharmazeutische Fabrik GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Eli Lilly Nederland B.V Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Orion Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. AstraZeneca UK Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Novartis Pharma Schweiz AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Key Raw Materials Price Trend
Figure 66. Manufacturing Cost Structure of Estrogen and Progesterone
Figure 67. Manufacturing Process Analysis of Estrogen and Progesterone
Figure 68. Estrogen and Progesterone Industrial Chain Analysis
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 71. Porter's Five Forces Analysis
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---